Description
IQVIA Holdings Inc.: AI & Technology Implementation to Position IQVIA At The Forefront Of Innovation In Life Sciences & Healthcare!
IQVIA marked a significant milestone in the second quarter of 2025 by surpassing $4 billion in quarterly revenue, a first in the company’s history. This revenue achievement was noted to be above the high end of the anticipated guidance. Adjusted EBITDA and adjusted diluted EPS also performed well, aligning with or eclipsing the expected targets.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
